Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
09/2001
09/11/2001US6287576 Biostimulating agent
09/11/2001US6287551 Method for treating herpes virus
09/11/2001US6287548 Treatment of acne, seborrheic dermatitis and other skin diseases with salt solution containing NACL
09/11/2001US6287541 Oral care compositions
09/11/2001US6287285 Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
09/11/2001CA2176205C Osteogenic product and process
09/07/2001WO2001064280A1 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
09/07/2001WO2001064251A2 Combination chemotherapy
09/07/2001WO2001064226A2 Farnesyl protein transferase inhibitor combinations with platinum compounds
09/07/2001WO2001064174A1 The use of xanthan gum for gelling cio2 and related species
09/07/2001WO2001064164A2 Nanocapsule encapsulation system and method
09/07/2001WO2000002815A3 Method for reducing the bromide content in an aqueous bromide-containing solution using hydrogen peroxide
09/07/2001EP1144311A3 Method for reducing the bromide content in an aqueous bromide-containing solution using hydrogen peroxide
09/07/2001CA2401304A1 Combination chemotherapy
09/07/2001CA2401002A1 The use of xanthan gum for gelling cio2 and related species
09/07/2001CA2400375A1 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
09/07/2001CA2397657A1 Farnesyl protein transferase inhibitor combinations with platinum compounds
09/05/2001EP1129715A1 Use of magnesium, calcium and silicon for the healing of different diseases and to the general well-being
09/05/2001EP1128824A1 Ionic silver complex
09/05/2001EP1128815A1 Process for preparing oral calcium compositions
09/05/2001EP1128813A1 An inhalation system
09/05/2001EP1128726A1 Teat disinfectant
09/05/2001EP0738114B1 Food products for preventing development of diseases and process for preparing same
09/05/2001CN1311685A Composite biocidal particles
09/05/2001CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid
09/05/2001CN1311628A Method and composition for the treatment of epidermal irritations and infections
09/05/2001CN1311022A Quick action health preserving liquid for stopping smoking and narcotic drugs
09/05/2001CN1311019A External use medicine for curing sexual disorder for male
09/05/2001CN1311001A Medicine for curing enteritis and bacillary dysentery
09/05/2001CN1070376C External use medicinal liquor for treating acute moist wart and prepn. method therefor
09/05/2001CN1070373C Health-care oral liquid-contg. the fruit of Chinese wolfberry and prepn. method therefor
09/05/2001CN1070368C Method for prepn. of pharmaceutical composition contg. imidazo [2,1-6] [3] benzoazepine derivatives
09/04/2001US6284790 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
09/04/2001US6284452 Administering aqueous solution containing potassium, magnesium, sodium, calcium, chloride, oncotic agent, carboxylic acid or salt, sugar and clotting factor
09/04/2001US6284288 Use of silica as agent for controlling the degradation of bicarbonate, resulting mixture and its application
09/04/2001US6284265 Antacid formulation
09/04/2001US6284140 Dialysis solution for peritoneal dialysis
09/04/2001CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process
08/2001
08/30/2001WO2001062264A2 Halotherapy method by inhalation of sodium chloride
08/30/2001WO2001062259A1 Method of treatment of prostate cancer
08/30/2001WO2001062213A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
08/30/2001WO2001062086A1 Nutritional intervention composition for enhancing and extending satiety
08/30/2001WO2001006985A3 Select amino acids as zinc-solubilizing agents in anti-viral genital formulations
08/30/2001CA2400892A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
08/29/2001EP1126884A2 Radiodense compositions
08/29/2001EP1126871A2 Combination therapy with vip antagonist
08/29/2001EP1126844A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
08/29/2001EP0869800B1 Acylglycine- and zinc salt-based antibacterial compound
08/29/2001CN1310012A Medicine for treating fever caused by lupus erythematosus and other immunological disease
08/29/2001CN1310006A Medicine for treating purpura caused by lupus erythematosus and other immunological disease
08/29/2001CN1309974A Jiangu capsule for strengthening bone
08/29/2001CN1070076C Medicine for treating cough & asthma and its producing method
08/29/2001CN1070073C Medicine for treating hypercoagulable blood and its preparation
08/29/2001CN1070072C Enterelcosis capsule
08/29/2001CN1070070C Chinese herb medicine for treating gout
08/29/2001CN1070067C Medicine for treating pointed condyloma and its preparation
08/29/2001CN1070062C Powder for treating tinnitus
08/29/2001CN1070054C Medicine for treating syphilopathy
08/28/2001US6281175 Medical emulsion for lubrication and delivery of drugs
08/28/2001US6280775 Antimicrobial oral composition and method of use
08/28/2001US6280761 Nicotine lozenge
08/28/2001US6280716 Method for treating itching of the vagina
08/23/2001WO2001060365A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
08/23/2001WO2001024803A3 Pharmaceutical compositions containing copper, salicylic acid and vitamines c
08/23/2001WO2001005356A3 Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant
08/23/2001US20010016601 Use of triaqua-u3-oxohexakis-u-propionatotrichromium(1+), [Cr3O(O2CCH2CH3)6(H2O)3]+, as a nutritional supplement or in treatment of medical conditions
08/23/2001US20010016600 Method of treating cancer using dithiocarbamate derivatives
08/23/2001US20010016577 Aqueous liquid containing active ingredient, clay, and a gum; protective coatings; retention; nausea, heartburn, diarrhea; side effect reduction
08/23/2001US20010016211 Comprising a solution having a subphysiologic pH, and a means for delivering the solution to the vascular site of a host, such as a catheter
08/23/2001US20010016196 Immunoliposomes that optimize internalization into target cells
08/23/2001CA2400197A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
08/22/2001EP1125575A1 Perfusate preparation for ophthalmic operation
08/22/2001EP1124580A1 Enhanced radiation therapy
08/22/2001EP1124567A2 Buffered compositions for dialysis
08/22/2001CN1309552A Pharmaceutical, hygienic and/or cosmetic compositions contg. sea water and uses
08/22/2001CN1308959A Medicine 'Yishenjieyu' for treating mental diseases (psychosis)
08/22/2001CN1308958A Medicine 'Huoxuexingshen' for treating mental diseases (psychosis)
08/22/2001CN1308957A Chinese medicine for treating mastoplasia and its preparing process
08/22/2001CN1308949A Medicine for treating diabetes and its preparing process
08/22/2001CN1308943A Chinese patent medicine for treating gastritis
08/22/2001CN1069834C Medical powder for treating acne
08/22/2001CN1069821C Iodine-enriched spirulina powder and its use
08/21/2001US6277835 Method of tumor treatment
08/21/2001US6277815 Solution for peritoneal dialysis
08/21/2001US6277387 Use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF αantagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained
08/21/2001US6277363 Containing activated chlorine dioxide and disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, or sodium monofluorophosphate
08/21/2001CA2205555C Use of nitric oxide-releasing agents for reducing metastasis risk
08/18/2001CA2337484A1 Fatty acid-containing composition
08/16/2001WO2001058918A2 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments
08/16/2001WO2001058458A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods
08/16/2001WO2001012180A3 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune responce
08/16/2001US20010014737 Antiinflammatory agents, cardiovascualr disorders, osteoporosis, anticancer agents
08/16/2001US20010014356 Silica coated zinc oxide adsorber for rough skin sensitivity
08/16/2001EP1123110A1 Compositions and methods for promoting tissue repair using heat shock proteins
08/16/2001EP1123097A1 Pharmaceutical composition containing decursin
08/16/2001EP1123072A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/16/2001EP0939635B1 Improved intraocular irrigating solution containing a polyamine antagonist
08/16/2001EP0649309B1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
08/15/2001CN1308545A Method of increasing bone toughness and stiffness and reducing fractures
08/15/2001CN1308522A Thixotropic formulations for filling capsules